Literature DB >> 10943536

Erythroderma.

M J Rothe1, T L Bialy, J M Grant-Kels.   

Abstract

Erythroderma can be caused by a variety of underlying dermatoses, infections, and systemic diseases. Many of the findings on history, physical examination, and laboratory evaluation are nondiagnostic. Distinctive clinical and laboratory features pointing to a specific disease may be evident, however. Conclusive clinicopathologic correlation may require multiple and repeated skin biopsies. The prognosis of erythroderma has improved with the advent of innovative dermatologic therapies (e.g., cyclosporine and synthetic retinoids) and advances in the management of systemic manifestations. Death from sepsis, cardiac failure, adult respiratory distress syndrome, and capillary leak syndrome continue to be rarely reported. A high index of suspicion for these complications must be maintained to facilitate early medical intervention.

Entities:  

Mesh:

Year:  2000        PMID: 10943536     DOI: 10.1016/s0733-8635(05)70189-3

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  3 in total

Review 1.  Dermacase. Erythroderma secondary to cutanous T-cell lymphoma.

Authors:  Irina Turchin; Benjamin Barankin
Journal:  Can Fam Physician       Date:  2005-07       Impact factor: 3.275

2.  A Suspected Case of Silodosin-Induced Erythroderma.

Authors:  Annie Liu; Lyne Giroux
Journal:  Drug Saf Case Rep       Date:  2015-12

3.  Erythroderma: review of a potentially life-threatening dermatosis.

Authors:  Cynthia Okoduwa; W C Lambert; R A Schwartz; E Kubeyinje; A Eitokpah; Smeeta Sinha; W Chen
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.